DE60334025D1 - Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays - Google Patents

Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays

Info

Publication number
DE60334025D1
DE60334025D1 DE60334025T DE60334025T DE60334025D1 DE 60334025 D1 DE60334025 D1 DE 60334025D1 DE 60334025 T DE60334025 T DE 60334025T DE 60334025 T DE60334025 T DE 60334025T DE 60334025 D1 DE60334025 D1 DE 60334025D1
Authority
DE
Germany
Prior art keywords
chemotherapeutic
assays
production
cell cultures
biological preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334025T
Other languages
English (en)
Inventor
Paul L Kornblith
Sheri Gimigliano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Predictive Oncology Inc
Original Assignee
Precision Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precision Therapeutics Inc filed Critical Precision Therapeutics Inc
Application granted granted Critical
Publication of DE60334025D1 publication Critical patent/DE60334025D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60334025T 2002-07-30 2003-07-30 Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays Expired - Lifetime DE60334025D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/208,480 US20040023375A1 (en) 2002-07-30 2002-07-30 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
PCT/US2003/023888 WO2004015065A2 (en) 2002-07-30 2003-07-30 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

Publications (1)

Publication Number Publication Date
DE60334025D1 true DE60334025D1 (de) 2010-10-14

Family

ID=31186831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334025T Expired - Lifetime DE60334025D1 (de) 2002-07-30 2003-07-30 Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays

Country Status (6)

Country Link
US (2) US20040023375A1 (de)
EP (1) EP1572969B1 (de)
AT (1) ATE479743T1 (de)
AU (1) AU2003261308A1 (de)
DE (1) DE60334025D1 (de)
WO (1) WO2004015065A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023375A1 (en) * 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US5728541A (en) * 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
US7276351B2 (en) 2003-09-10 2007-10-02 Seahorse Bioscience Method and device for measuring multiple physiological properties of cells
US8658349B2 (en) * 2006-07-13 2014-02-25 Seahorse Bioscience Cell analysis apparatus and method
US20070087401A1 (en) * 2003-10-17 2007-04-19 Andy Neilson Analysis of metabolic activity in cells using extracellular flux rate measurements
DE102005015953A1 (de) * 2005-04-07 2006-10-12 Medizinische Hochschule Hannover Verfahren zur Anreicherung und ex vivo Kultivierung von Brustprimärzellen
EP1929306A4 (de) * 2005-09-01 2009-11-11 Precision Therapeutics Inc Chemosensible assays, die tumorzellen mit persistenten phänotypischen merkmalen
US20100216168A1 (en) * 2007-03-23 2010-08-26 Precision Therapeutics, Inc. Methods for evaluating angiogenic potential in culture
US8187800B2 (en) 2007-10-15 2012-05-29 Precision Therapeutics, Inc. Methods for selecting active agents for cancer treatment
DK2250498T3 (da) 2008-02-25 2013-02-04 Nestec Sa Lægemiddelvalg til brystcancerterapi under anvendelse af antistof-baserede arrays
US20100311084A1 (en) * 2008-05-14 2010-12-09 Precision Therapeutics, Inc. Methods for predicting a patient's response to egfr inhibitors
US8202702B2 (en) * 2008-10-14 2012-06-19 Seahorse Bioscience Method and device for measuring extracellular acidification and oxygen consumption rate with higher precision
US20110238322A1 (en) * 2008-11-03 2011-09-29 Precision Therapeutics, Inc. Methods of simulating chemotherapy for a patient
US20110014644A1 (en) 2009-06-22 2011-01-20 Precision Therapeutics, Inc. Methods for predicting a cancer patient's response to antifolate chemotherapy
EP2454598B1 (de) 2009-07-15 2017-03-22 DiaTech Holdings, Inc. Wirkstoffauswahl für eine magenkrebstherapie anhand von antikörper-arrays
CA2788575C (en) 2010-01-28 2015-04-21 Shuichi Takayama Hanging drop devices, systems and/or methods
WO2014078379A2 (en) 2012-11-13 2014-05-22 Seahorse Bioscience Apparatus and methods for three-dimensional tissue measurements based on controlled media flow
US10118177B2 (en) 2014-06-02 2018-11-06 Seahorse Bioscience Single column microplate system and carrier for analysis of biological samples

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US168679A (en) * 1875-10-11 Improvement in variable measures
US192638A (en) * 1877-07-03 Improvement in umbrella tip-cups
US4423145A (en) * 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
US4668618A (en) * 1981-09-14 1987-05-26 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US4559299A (en) * 1983-02-04 1985-12-17 Brown University Research Foundation Inc. Cytotoxicity assays in cell culturing devices
US4937187A (en) * 1983-02-04 1990-06-26 Brown University Research Foundation Methods for separating malignant cells from clinical specimens
US4937182A (en) * 1985-12-19 1990-06-26 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US4816395A (en) * 1985-12-19 1989-03-28 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4996145A (en) * 1987-10-27 1991-02-26 Oncotech Incorporated Method for detecting immune-mediated cytotoxicity
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5874218A (en) * 1990-06-11 1999-02-23 Nexstar Pharmaceuticals, Inc. Method for detecting a target compound in a substance using a nucleic acid ligand
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US5270172A (en) * 1991-04-26 1993-12-14 Dekk-Tek, Inc. Method to predict tumor response to therapy
US5407653A (en) * 1991-06-26 1995-04-18 Brigham And Women's Hospital Evaluation of the multidrug resistance phenotype
CA2121129A1 (en) * 1991-10-29 1993-05-13 Patrick Soon-Shiong Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
WO1994000470A1 (en) * 1992-06-30 1994-01-06 The Wistar Institute Of Anatomy And Biology DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES
US5585265A (en) * 1992-11-30 1996-12-17 Gillette Company Human corneal epithelial cell lines with extended lifespan
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5888765A (en) * 1995-06-23 1999-03-30 President And Fellows Of Harvard College Endothelial-cell specific promoter
US6274576B1 (en) * 1995-06-27 2001-08-14 The Henry Jackson Foundation For The Advancement Of Military Medicine Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5728541A (en) * 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US20040023375A1 (en) 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US6416967B2 (en) * 1996-07-12 2002-07-09 Precision Therapeutics, Inc. Method of using multicellular particulates to analyze malignant or hyperproliferative tissue
US20020168679A1 (en) 1998-06-11 2002-11-14 Gregory J. Naus Staining agents and protocols for characterizing malignant cells in culture
US6008007A (en) * 1997-01-31 1999-12-28 Oncotech, Inc. Radiation resistance assay for predicting treatment response and clinical outcome
US5840507A (en) * 1997-03-19 1998-11-24 Oncotech, Inc. Methods for cancer prognosis and diagnosis
US5972639A (en) * 1997-07-24 1999-10-26 Irori Fluorescence-based assays for measuring cell proliferation
US6074874A (en) * 1997-08-29 2000-06-13 University Of Pittsburgh Epithelial cell cultures for in vitro testing
US6111092A (en) * 1998-06-03 2000-08-29 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding DRT111 and uses thereof
US6664062B1 (en) * 1998-07-20 2003-12-16 Nuvelo, Inc. Thymidylate synthase gene sequence variances having utility in determining the treatment of disease
WO2000022142A2 (en) 1998-10-13 2000-04-20 Onyx Pharmaceuticals, Inc. Cell signaling polypeptides and nucleic acids
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
EP1059352A1 (de) * 1999-06-08 2000-12-13 Oncodia AG Langzeitkultur humaner Karzinome
WO2001033228A2 (en) * 1999-11-03 2001-05-10 Oncotech, Inc. Cancer diagnosis employing cell-sorting and gene-profiles
EP1228370A2 (de) 1999-11-10 2002-08-07 Structural Bioinformatics Inc. Computerableitbare proteinstrukturen in pharmakogenomik
AU2001240998A1 (en) 2000-03-06 2001-09-17 Technion Research And Development Foundation Ltd. Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy
ATE404698T1 (de) 2000-04-18 2008-08-15 Virco Bvba Methode zur bestimmung der resistenz gegen medikamente
AU2002224435A1 (en) 2000-10-18 2002-04-29 Precision Therapeutics, Inc. Method for tandem genomic/proteomic analyses of proliferating cells
DE60234440D1 (de) 2001-01-12 2009-12-31 Univ Washington Mdr1-varianten und verfahren zu ihrer verwendung
US20040086888A1 (en) * 2001-10-18 2004-05-06 Kornblith Paul L Method for tandem genomic/proteomic analysis of proliferating cells
AU2002352799A1 (en) 2001-11-20 2003-06-10 Oncomedx, Inc. Methods for evaluating drug-resistance gene expression in the cancer patient

Also Published As

Publication number Publication date
AU2003261308A1 (en) 2004-02-25
AU2003261308A8 (en) 2004-02-25
WO2004015065A2 (en) 2004-02-19
US20040023375A1 (en) 2004-02-05
US7972769B2 (en) 2011-07-05
WO2004015065A3 (en) 2006-10-05
EP1572969A4 (de) 2007-06-06
EP1572969B1 (de) 2010-09-01
ATE479743T1 (de) 2010-09-15
US20070059821A1 (en) 2007-03-15
EP1572969A2 (de) 2005-09-14

Similar Documents

Publication Publication Date Title
DE60334025D1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
SG151259A1 (en) Cardiomyocyte production
WO2006027229A8 (de) Skalierbarer prozess zur kultivierung undifferenzierter stammzellen in suspension
ATE406435T1 (de) Methoden zur züchtung von tierzellen
ATE408004T1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
WO2001081549A3 (en) Hepatocyte lineage cells derived from pluripotent stem cells
DE50312269D1 (de) Verfahren und vorrichtung zum züchten von zellen
SG158025A1 (en) Growth medium c. histolyticum without ingredients of mamalian sources
DE602007012290D1 (de) Mischzell-populationen für die gewebereparatur und trenntechnik für die zellaufbereitung
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
HU197766B (en) Process for producing cell lines independent of serum
RU2010103046A (ru) Культивирование отдельных плюрипотентных стволовых клеток
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
ATE517176T1 (de) Verfahren zur kultivierung von geschmackszellen aus säugern
WO2003010304A3 (de) Verfahren zur herstellung isolierter zellkulturen, kulturmedium zur kultivierung von zellkulturen und zellkultur
ATE336567T1 (de) Zellkulturmedium
NO20006051L (no) Fremgangsmåte for fremstilling av dyrkning av celleaggregater referert til som primmorfer fra dissosierte celler fra svamper, koraller og andre invertebrater, samt anvendelse av disse
ATE201908T1 (de) Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase- aktivität
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
EP1477555A3 (de) Verfahren zur Kultivierung von Bakterienzellen der Gattung Enterococcus und Verfahren zur Herstellung der abgetöteten Bakterienzellen der Gattung Enterococcus
CN103589680A (zh) 一种海洋弹性蛋白酶myroilysin在制备无细胞真皮基质中的应用
IL179318A (en) Methods for cultivating stem cells, cell cultures and the use of an egg for the cultivation of the stem cells